Pulmonary Arterial Hypertension

Latest News

naphat-stock.adobe.com
Gossamer Study Finds Seralutinib Has Long-Lasting Effects in PAH

February 5th 2025

Gossamer also reported encouraging preclinical data related to the combination of seralutinib and Winrevair.

Another Trial of Winrevair Stopped Early Due to Positive Efficacy
Another Trial of Winrevair Stopped Early Due to Positive Efficacy

January 30th 2025

Winrevair Gets Nod From UK Regulators
Winrevair Gets Nod From UK Regulators

January 13th 2025

Analysis Finds Winrevair Effective Across Cardiac Index Groups
Analysis Finds Winrevair Effective Across Cardiac Index Groups

December 17th 2024

Winrevair Advanced PAH Trial Stopped Early Due to ‘Overwhelming’ Efficacy
Winrevair Advanced PAH Trial Stopped Early Due to ‘Overwhelming’ Efficacy

December 10th 2024

More News

© 2025 MJH Life Sciences

All rights reserved.